Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Candonilimab”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Testing effectiveness (Phase 2)UnknownNCT05760599
What this trial is testing

Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T

Who this might be right for
Hepatocellular Carcinoma
Shi Ming 30
Testing effectiveness (Phase 2)UnknownNCT05896787
What this trial is testing

Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 45
Testing effectiveness (Phase 2)Looking for participantsNCT06587425
What this trial is testing

The Efficacy and Safety of LM-302 in Combination With Candonilimab and Capecitabine for First-Line Treatment in Patients With Unresectable Advanced, Recurrent, or Metastatic CLDN18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
Shanghai Zhongshan Hospital 50
Testing effectiveness (Phase 2)UnknownNCT05853172
What this trial is testing

Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ Cancer

Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06728631
What this trial is testing

Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL

Who this might be right for
Oral Cavity CancerPremalignant Lesion
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 22
Testing effectiveness (Phase 2)UnknownNCT06455254
What this trial is testing

Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM

Who this might be right for
CRC
Jin-hong Chen 44
Testing effectiveness (Phase 2)WithdrawnNCT05886257
What this trial is testing

Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T

Who this might be right for
Hepatocellular Carcinoma
Shi Ming
Testing effectiveness (Phase 2)Active Not RecruitingNCT05994001
What this trial is testing

Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

Who this might be right for
Biliary Tract CancerCandonilimabClaudin 18.2
Shanghai Zhongshan Hospital 78